Stockreport

Syntis Bio Launches to Revolutionize Oral Therapy for Obesity, Diabetes and Rare Diseases by Unlocking the Full Therapeutic Potential of the Small Intestine [Yahoo! Finance]

Codexis, Inc.  (CDXS) 
Last codexis, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.codexis.com/investors
PDF Orphan pediatric portfolio acquired from Codexis expands pipeline with first-in-class oral enzyme replacement therapies for homocystinuria and maple syrup urine disease [Read more]